Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters

Table 1 Clinicopathological parameters of gastric cancer patients studied in tissue microarray

	N(%)	GCRG213p negative	GCRG213p positive	P value
Gender
Male	144(82.28%)	31	113	0.111
Female	31(17.72%)	11	20
Age
<65 year	104(59.43%)	31	73	0.029
≥65 year	71(40.57%)	11	60
Smoking
Yes	45(27.27%)	7	38	0.278
No	120(72.73%)	30	90
Drinking
Yes	28(16.97%)	2	26	0.060
No	137(83.03%)	35	102
Family history of tumor
Yes	14(8.43%)	2	12	0.639
No	152(91.57%)	36	116
Tumor location
Cardiac	48(27.43%)	8	40	0.360
Body	37(21.14%)	10	27
Antrum	90(51.43%)	24	66
Tumor size (cm)
≤1	11(6.29%)	3	8	0.506
1-3	42(24.00%)	13	29
>3	122(69.71%)	26	96
Depth of invasion
T1	46(26.28%)	12	34	0.635
T2	21(12.00%)	7	14
T3	33(18.86%)	6	27
T4	75(42.86%)	17	58
Lymph node involvement
Yes	75(42.86%)	16	59	0.592
No	100(57.14%)	26	74
Grade of tumor differentiation
Well	10(5.71%)	0	10	0.001
Moderate	40(22.86%)	4	36
Poor	103(58.86%)	27	76
Signet ring cell	22(12.57%)	11	11
Tumour stage (TNM)
0	21(12.00%)	3	18	0.217
Ia	14(8.00%)	6	8
Ib	41(23.43%)	10	31
II	60(34.29%)	17	43
IIIa	39(22.28%)	6	33
Lauren’s classification
Intestinal type	153(87.43%)	31	122	0.015
Diffuse type	22(12.57%)	11	11
Resection margin
Presence	6(3.43%)	0	6	0.361
Absence	169(96.57%)	42	127
Microvascular invasion
Presence	20(11.43%)	5	15	0.911
Absence	155(88.57%)	37	118
Status
alive	121(71.18%)	30	91	0.483
dead	49(28.82%)	9	40
5 year survival
<5 yr	47(43.93%)	12	48	0.871
> = 5 yr	60(50.07%)	10	37

ISSN: 1471-2407